Hepatitis B Reactivation in Immunosupressed Patients, Prophylaxis and Management

Authors

  • Ulfa Kholili
  • Tri Yanti

DOI:

https://doi.org/10.24871/182201798-103

Keywords:

hepatitis B reactivation, immunosuppresive, chemotherapy, prophylaxis, treatment

Abstract

Hepatitis B virus (HBV) reactivation is a clinical problem associated with high morbidity and mortality rates. Currently, this incidence seems to be increasing around the world. The reactivation commonly developes in immunosuppressed individuals, although it may also occur spontaneously. Individuals who develop malignancy with chronic hepatitis B virus infection are at high-risk for hepatitis B virus reactivation, since they are closely related to immunosuppression, especially when undergoing chemotherapy. The loss of immune control in these patients may results in the reactivation of HBV replication within hepatocytes. This review article will focus on HBV reactivation related to immunosuppressed patients, immunosuppressive drug classes and corresponding risk estimates of hepatitis B virus reactivation, screening test recommended before getting this drugs, choice of antiviral drugs for prophylaxis, and duration of prophylaxis treatment based on EASL, AASLD and APASL guidelines.

Downloads

Published

2020-07-19

How to Cite

Kholili, U., & Yanti, T. (2020). Hepatitis B Reactivation in Immunosupressed Patients, Prophylaxis and Management. The Indonesian Journal of Gastroenterology, Hepatology, and Digestive Endoscopy, 18(2), 98–103. https://doi.org/10.24871/182201798-103

Issue

Vol. 18 No. 2 (2017): VOLUME 18, NUMBER 2, AUGUST 2017

Section

Review Article

License

Authors who publish with this journal agree to the following terms:

a. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

b. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

c. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).